News
-
-
-
-
-
-
PRESS RELEASE
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
Heidelberg Pharma granted orphan drug designation by FDA for its ATAC candidate HDP-101, targeting multiple myeloma. The designation provides significant benefits for the development and potential marketing of the drug -
-
-
PRESS RELEASE
Life Chemicals Partners With Bioz to Provide Customers With Product Usage Information From Scientific Literature
Bioz, Inc. and Life Chemicals announce partnership to enhance access to product usage info extracted from scientific literature. Bioz Badges facilitate direct interaction with journal snippets on Life Chemicals' website -
REGULATED PRESS RELEASE
Reporting détaillé et agrégé Accor du 20 mars au 26 mars 2024